| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/JAMADERMATOL.2014.2094 |
| P8608 | Fatcat ID | release_qjckcc4nb5gi7iwe3522fw4ftm |
| P932 | PMC publication ID | 4728300 |
| P698 | PubMed publication ID | 25322196 |
| P50 | author | Joel M Gelfand | Q60659843 |
| Andrea B. Troxel | Q43414494 | ||
| P2093 | author name string | Nehal N Mehta | |
| Stephen E Kimmel | |||
| David J Margolis | |||
| Daniel B Shin | |||
| Junko Takeshita | |||
| Shuwei Wang | |||
| P2860 | cites work | Incidence of cardiovascular disease in individuals with psoriasis: a systematic review and meta-analysis | Q27007133 |
| Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials | Q28213612 | ||
| Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study | Q28281870 | ||
| Pharmacological undertreatment of coronary risk factors in patients with psoriasis: observational study of the Danish nationwide registries | Q28730205 | ||
| Prevalence of cardiovascular risk factors in patients with psoriasis | Q60711908 | ||
| Risk of Myocardial Infarction in Patients With Psoriasis | Q60711909 | ||
| Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction | Q33642021 | ||
| Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses | Q33767803 | ||
| The risk of stroke in patients with psoriasis | Q33831094 | ||
| Psoriasis and hypertension severity: results from a case-control study | Q33867611 | ||
| Reliability, validity and responsiveness to change of the Patient Report of Extent of Psoriasis Involvement (PREPI) for measuring body surface area affected by psoriasis | Q33879351 | ||
| Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database | Q33951592 | ||
| Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K. | Q34253312 | ||
| The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies | Q34318384 | ||
| Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis | Q34327755 | ||
| Effect of pay for performance on the management and outcomes of hypertension in the United Kingdom: interrupted time series study | Q34520451 | ||
| Validity of The Health Improvement Network (THIN) for the study of psoriasis. | Q34721703 | ||
| Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review | Q34812877 | ||
| The impact of nonsteroidal anti-inflammatory drugs on blood pressure, with an emphasis on newer agents | Q35085355 | ||
| Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom | Q35753936 | ||
| Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction | Q36229028 | ||
| Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis | Q36321202 | ||
| Comorbidity in patients with cancer of the head and neck: prevalence and impact on treatment and prognosis | Q36409228 | ||
| Prevalence and treatment patterns of psoriatic arthritis in the UK. | Q36612234 | ||
| Symptoms of depression and anxiety and adherence to antihypertensive medication | Q36656265 | ||
| Multimorbidity and blood pressure control in 37 651 hypertensive patients from Danish general practice. | Q36701801 | ||
| Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies | Q36824796 | ||
| Involvement of tumor necrosis factor-alpha in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy | Q37330943 | ||
| Comorbidities of chronic obstructive pulmonary disease. | Q37972495 | ||
| The association between psoriasis and dyslipidaemia: a systematic review | Q38056160 | ||
| The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies | Q38064779 | ||
| High prevalence of cardiovascular diseases and enhanced activity of the renin-angiotensin system in psoriatic patients. | Q41485823 | ||
| Evaluating hypertension control in a managed care setting | Q41707752 | ||
| Psoriasis and risk of cardiovascular disease: a meta-analysis of cohort studies | Q43937313 | ||
| Hypertension, angiotensin II, and oxidative stress | Q44035389 | ||
| Psoriasis prevalence among adults in the United States | Q46308366 | ||
| Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003-2004. | Q46361523 | ||
| Patterns of comorbidities in newly diagnosed COPD and asthma in primary care | Q47706912 | ||
| The prognostic impact of comorbidities on renal cancer, 1995 to 2006: a Danish population based study | Q48851550 | ||
| Endothelin-1 levels are increased in sera and lesional skin extracts of psoriatic patients and correlate with disease severity. | Q50903380 | ||
| Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis. | Q51366532 | ||
| Epidemiology of psoriatic arthritis in the population of the United States. | Q53276933 | ||
| Detection and control of high blood pressure in the community : Do we need a wake-up call? | Q54378147 | ||
| Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis | Q57950827 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | United Kingdom | Q145 |
| P304 | page(s) | 161-169 | |
| P577 | publication date | 2015-02-01 | |
| P1433 | published in | JAMA Dermatology | Q3918707 |
| P1476 | title | Effect of psoriasis severity on hypertension control: a population-based study in the United Kingdom | |
| P478 | volume | 151 |
| Q37015832 | Assessing the risk of incident hypertension and chronic kidney disease after exposure to shock wave lithotripsy and ureteroscopy |
| Q47218445 | Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis |
| Q91778340 | Cardiovascular Comorbidities in Psoriatic Disease |
| Q92148213 | Cardiovascular Risk in Psoriasis Patients: Clinical, Functional and Morphological Parameters |
| Q37682855 | Evaluation of psoriasis patients' attitudes toward benefit-risk and therapeutic trade-offs in their choice of treatments |
| Q58708700 | Hypertension and risk of psoriasis incidence: An 11-year nationwide population-based cohort study |
| Q39328180 | Incidence and Management of Cardiovascular Risk Factors in Psoriatic Arthritis and Rheumatoid Arthritis: A Population-Based Study |
| Q42318223 | Inhibition of Interleukin 17-A but not Interleukin-17F Signaling Lowers Blood Pressure and Reduces End-organ Inflammation in Angiotensin II-induced Hypertension. |
| Q92983960 | Interleukin-17 Drives Interstitial Entrapment of Tissue Lipoproteins in Experimental Psoriasis |
| Q40690970 | National Heart, Lung, and Blood Institute Working Group Report on Salt in Human Health and Sickness: Building on the Current Scientific Evidence |
| Q90248096 | Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities |
| Q46180528 | Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment |
| Q35962417 | Psoriasis and Cardiovascular Risk: Strength in Numbers Part 3 |
| Q36016012 | Psoriasis and Diabetes: A Multicenter Study in 222078 Type 2 Diabetes Patients Reveals High Levels of Depression |
| Q30235889 | Psoriasis and comorbid diseases: Epidemiology |
| Q30235888 | Psoriasis and comorbid diseases: Implications for management |
| Q47613035 | Psoriasis and the risk of diabetes: A prospective population-based cohort study. |
| Q37622768 | Response to 'Kidney disease in moderate-to-severe psoriasis: a critical appraisal' |
| Q52314887 | Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences. |
| Q93078749 | Telmisartan Lowers Elevated Blood Pressure in Psoriatic Mice without Attenuating Vascular Dysfunction and Inflammation |
| Q37362082 | Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2016 MauiDerm Meeting based on presentations by. |
| Q30250110 | Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms |
Search more.